Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol a in polycystic ovary syndrome: a case–control study
Background Polycystic Ovary Syndrome (PCOS) is an endocrine-metabolic disorder that affects approximately 6-10% of women of child-bearing age. Although preliminary studies suggest that certain pollutants may act as endocrine disruptors in animals, little is known about their potential association wi...
Saved in:
| Published in | BMC endocrine disorders Vol. 14; no. 1; p. 86 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
28.10.2014
BioMed Central Ltd Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1472-6823 1472-6823 |
| DOI | 10.1186/1472-6823-14-86 |
Cover
| Abstract | Background
Polycystic Ovary Syndrome (PCOS) is an endocrine-metabolic disorder that affects approximately 6-10% of women of child-bearing age. Although preliminary studies suggest that certain pollutants may act as endocrine disruptors in animals, little is known about their potential association with PCOS. The objective of this case-control pilot study is to determine whether women with PCOS have higher concentrations of specific environmental contaminants compared to women who have not developed PCOS.
Methods
Fifty-two PCOS case-patients (diagnosed using the National Institutes of Health 1990 definition) and 50 controls were recruited in 2007–2008, from an urban academic medical center in Los Angeles, CA. Brominated diphenyl ethers, polychlorinated biphenyls (PCBs), organochlorine pesticides, and perfluorinated compounds (PFCs) were measured in serum, and phthalates metabolites and bisphenol A (BPA) in urine.
Results
PCOS case-patients had significantly higher geometric mean (GM) serum concentrations of two PFCs: perfluorooctanoate (PFOA) (GM
cases
= 4.1 μg/L, GM
controls
= 2.3 μg/L; p = 0.001) and perfluorooctane sulfonate (PFOS) (GM
cases
= 8.2 μg/L, GM
controls
= 4.9 μg/L; p = 0.01), and lower urinary concentrations of monobenzyl phthalate (mBzP) (GM
cases
= 7.5 μg/g creatinine, GM
controls
= 11.7 μg/g creatinine; p = 0.02). Logistic regression, controlling for body mass index, age and race, identified an increased likelihood of PCOS in subjects with higher serum concentrations of PFOA and PFOS (adjusted-ORs = 5.8–6.9, p < 0.05), and with lower urine concentrations of mBzP and mono-n-butyl phthalate (mBP) (aORs = 0.14–0.25, p < 0.05).
Conclusions
Our data suggest that PCOS case-patients may differ from controls in their environmental contaminant profile. PCOS subjects had higher serum concentrations of two PFCs, PFOA and PFOS, and lower urine concentrations of mBP and mBzP. Future studies are needed to confirm these preliminary findings and determine if these chemicals or their precursors may have a role in the pathogenesis of PCOS. |
|---|---|
| AbstractList | Polycystic Ovary Syndrome (PCOS) is an endocrine-metabolic disorder that affects approximately 6-10% of women of child-bearing age. Although preliminary studies suggest that certain pollutants may act as endocrine disruptors in animals, little is known about their potential association with PCOS. The objective of this case-control pilot study is to determine whether women with PCOS have higher concentrations of specific environmental contaminants compared to women who have not developed PCOS.BACKGROUNDPolycystic Ovary Syndrome (PCOS) is an endocrine-metabolic disorder that affects approximately 6-10% of women of child-bearing age. Although preliminary studies suggest that certain pollutants may act as endocrine disruptors in animals, little is known about their potential association with PCOS. The objective of this case-control pilot study is to determine whether women with PCOS have higher concentrations of specific environmental contaminants compared to women who have not developed PCOS.Fifty-two PCOS case-patients (diagnosed using the National Institutes of Health 1990 definition) and 50 controls were recruited in 2007-2008, from an urban academic medical center in Los Angeles, CA. Brominated diphenyl ethers, polychlorinated biphenyls (PCBs), organochlorine pesticides, and perfluorinated compounds (PFCs) were measured in serum, and phthalates metabolites and bisphenol A (BPA) in urine.METHODSFifty-two PCOS case-patients (diagnosed using the National Institutes of Health 1990 definition) and 50 controls were recruited in 2007-2008, from an urban academic medical center in Los Angeles, CA. Brominated diphenyl ethers, polychlorinated biphenyls (PCBs), organochlorine pesticides, and perfluorinated compounds (PFCs) were measured in serum, and phthalates metabolites and bisphenol A (BPA) in urine.PCOS case-patients had significantly higher geometric mean (GM) serum concentrations of two PFCs: perfluorooctanoate (PFOA) (GMcases = 4.1 μg/L, GMcontrols = 2.3 μg/L; p = 0.001) and perfluorooctane sulfonate (PFOS) (GMcases = 8.2 μg/L, GMcontrols = 4.9 μg/L; p = 0.01), and lower urinary concentrations of monobenzyl phthalate (mBzP) (GMcases = 7.5 μg/g creatinine, GMcontrols = 11.7 μg/g creatinine; p = 0.02). Logistic regression, controlling for body mass index, age and race, identified an increased likelihood of PCOS in subjects with higher serum concentrations of PFOA and PFOS (adjusted-ORs = 5.8-6.9, p < 0.05), and with lower urine concentrations of mBzP and mono-n-butyl phthalate (mBP) (aORs = 0.14-0.25, p < 0.05).RESULTSPCOS case-patients had significantly higher geometric mean (GM) serum concentrations of two PFCs: perfluorooctanoate (PFOA) (GMcases = 4.1 μg/L, GMcontrols = 2.3 μg/L; p = 0.001) and perfluorooctane sulfonate (PFOS) (GMcases = 8.2 μg/L, GMcontrols = 4.9 μg/L; p = 0.01), and lower urinary concentrations of monobenzyl phthalate (mBzP) (GMcases = 7.5 μg/g creatinine, GMcontrols = 11.7 μg/g creatinine; p = 0.02). Logistic regression, controlling for body mass index, age and race, identified an increased likelihood of PCOS in subjects with higher serum concentrations of PFOA and PFOS (adjusted-ORs = 5.8-6.9, p < 0.05), and with lower urine concentrations of mBzP and mono-n-butyl phthalate (mBP) (aORs = 0.14-0.25, p < 0.05).Our data suggest that PCOS case-patients may differ from controls in their environmental contaminant profile. PCOS subjects had higher serum concentrations of two PFCs, PFOA and PFOS, and lower urine concentrations of mBP and mBzP. Future studies are needed to confirm these preliminary findings and determine if these chemicals or their precursors may have a role in the pathogenesis of PCOS.CONCLUSIONSOur data suggest that PCOS case-patients may differ from controls in their environmental contaminant profile. PCOS subjects had higher serum concentrations of two PFCs, PFOA and PFOS, and lower urine concentrations of mBP and mBzP. Future studies are needed to confirm these preliminary findings and determine if these chemicals or their precursors may have a role in the pathogenesis of PCOS. Polycystic Ovary Syndrome (PCOS) is an endocrine-metabolic disorder that affects approximately 6-10% of women of child-bearing age. Although preliminary studies suggest that certain pollutants may act as endocrine disruptors in animals, little is known about their potential association with PCOS. The objective of this case-control pilot study is to determine whether women with PCOS have higher concentrations of specific environmental contaminants compared to women who have not developed PCOS. Fifty-two PCOS case-patients (diagnosed using the National Institutes of Health 1990 definition) and 50 controls were recruited in 2007-2008, from an urban academic medical center in Los Angeles, CA. Brominated diphenyl ethers, polychlorinated biphenyls (PCBs), organochlorine pesticides, and perfluorinated compounds (PFCs) were measured in serum, and phthalates metabolites and bisphenol A (BPA) in urine. PCOS case-patients had significantly higher geometric mean (GM) serum concentrations of two PFCs: perfluorooctanoate (PFOA) (GM.sub.cases = 4.1 [mu]g/L, GM.sub.controls = 2.3 [mu]g/L; p = 0.001) and perfluorooctane sulfonate (PFOS) (GM.sub.cases = 8.2 [mu]g/L, GM.sub.controls = 4.9 [mu]g/L; p = 0.01), and lower urinary concentrations of monobenzyl phthalate (mBzP) (GM.sub.cases = 7.5 [mu]g/g creatinine, GM.sub.controls = 11.7 [mu]g/g creatinine; p = 0.02). Logistic regression, controlling for body mass index, age and race, identified an increased likelihood of PCOS in subjects with higher serum concentrations of PFOA and PFOS (adjusted-ORs = 5.8-6.9, p < 0.05), and with lower urine concentrations of mBzP and mono-n-butyl phthalate (mBP) (aORs = 0.14-0.25, p < 0.05). Our data suggest that PCOS case-patients may differ from controls in their environmental contaminant profile. PCOS subjects had higher serum concentrations of two PFCs, PFOA and PFOS, and lower urine concentrations of mBP and mBzP. Future studies are needed to confirm these preliminary findings and determine if these chemicals or their precursors may have a role in the pathogenesis of PCOS. Doc number: 86 Abstract Background: Polycystic Ovary Syndrome (PCOS) is an endocrine-metabolic disorder that affects approximately 6-10% of women of child-bearing age. Although preliminary studies suggest that certain pollutants may act as endocrine disruptors in animals, little is known about their potential association with PCOS. The objective of this case-control pilot study is to determine whether women with PCOS have higher concentrations of specific environmental contaminants compared to women who have not developed PCOS. Methods: Fifty-two PCOS case-patients (diagnosed using the National Institutes of Health 1990 definition) and 50 controls were recruited in 2007-2008, from an urban academic medical center in Los Angeles, CA. Brominated diphenyl ethers, polychlorinated biphenyls (PCBs), organochlorine pesticides, and perfluorinated compounds (PFCs) were measured in serum, and phthalates metabolites and bisphenol A (BPA) in urine. Results: PCOS case-patients had significantly higher geometric mean (GM) serum concentrations of two PFCs: perfluorooctanoate (PFOA) (GMcases = 4.1 μg/L, GMcontrols = 2.3 μg/L; p = 0.001) and perfluorooctane sulfonate (PFOS) (GMcases = 8.2 μg/L, GMcontrols = 4.9 μg/L; p = 0.01), and lower urinary concentrations of monobenzyl phthalate (mBzP) (GMcases = 7.5 μg/g creatinine, GMcontrols = 11.7 μg/g creatinine; p = 0.02). Logistic regression, controlling for body mass index, age and race, identified an increased likelihood of PCOS in subjects with higher serum concentrations of PFOA and PFOS (adjusted-ORs = 5.8-6.9, p < 0.05), and with lower urine concentrations of mBzP and mono-n-butyl phthalate (mBP) (aORs = 0.14-0.25, p < 0.05). Conclusions: Our data suggest that PCOS case-patients may differ from controls in their environmental contaminant profile. PCOS subjects had higher serum concentrations of two PFCs, PFOA and PFOS, and lower urine concentrations of mBP and mBzP. Future studies are needed to confirm these preliminary findings and determine if these chemicals or their precursors may have a role in the pathogenesis of PCOS. Background Polycystic Ovary Syndrome (PCOS) is an endocrine-metabolic disorder that affects approximately 6-10% of women of child-bearing age. Although preliminary studies suggest that certain pollutants may act as endocrine disruptors in animals, little is known about their potential association with PCOS. The objective of this case-control pilot study is to determine whether women with PCOS have higher concentrations of specific environmental contaminants compared to women who have not developed PCOS. Methods Fifty-two PCOS case-patients (diagnosed using the National Institutes of Health 1990 definition) and 50 controls were recruited in 2007–2008, from an urban academic medical center in Los Angeles, CA. Brominated diphenyl ethers, polychlorinated biphenyls (PCBs), organochlorine pesticides, and perfluorinated compounds (PFCs) were measured in serum, and phthalates metabolites and bisphenol A (BPA) in urine. Results PCOS case-patients had significantly higher geometric mean (GM) serum concentrations of two PFCs: perfluorooctanoate (PFOA) (GM cases = 4.1 μg/L, GM controls = 2.3 μg/L; p = 0.001) and perfluorooctane sulfonate (PFOS) (GM cases = 8.2 μg/L, GM controls = 4.9 μg/L; p = 0.01), and lower urinary concentrations of monobenzyl phthalate (mBzP) (GM cases = 7.5 μg/g creatinine, GM controls = 11.7 μg/g creatinine; p = 0.02). Logistic regression, controlling for body mass index, age and race, identified an increased likelihood of PCOS in subjects with higher serum concentrations of PFOA and PFOS (adjusted-ORs = 5.8–6.9, p < 0.05), and with lower urine concentrations of mBzP and mono-n-butyl phthalate (mBP) (aORs = 0.14–0.25, p < 0.05). Conclusions Our data suggest that PCOS case-patients may differ from controls in their environmental contaminant profile. PCOS subjects had higher serum concentrations of two PFCs, PFOA and PFOS, and lower urine concentrations of mBP and mBzP. Future studies are needed to confirm these preliminary findings and determine if these chemicals or their precursors may have a role in the pathogenesis of PCOS. Polycystic Ovary Syndrome (PCOS) is an endocrine-metabolic disorder that affects approximately 6-10% of women of child-bearing age. Although preliminary studies suggest that certain pollutants may act as endocrine disruptors in animals, little is known about their potential association with PCOS. The objective of this case-control pilot study is to determine whether women with PCOS have higher concentrations of specific environmental contaminants compared to women who have not developed PCOS. Fifty-two PCOS case-patients (diagnosed using the National Institutes of Health 1990 definition) and 50 controls were recruited in 2007-2008, from an urban academic medical center in Los Angeles, CA. Brominated diphenyl ethers, polychlorinated biphenyls (PCBs), organochlorine pesticides, and perfluorinated compounds (PFCs) were measured in serum, and phthalates metabolites and bisphenol A (BPA) in urine. PCOS case-patients had significantly higher geometric mean (GM) serum concentrations of two PFCs: perfluorooctanoate (PFOA) (GMcases = 4.1 μg/L, GMcontrols = 2.3 μg/L; p = 0.001) and perfluorooctane sulfonate (PFOS) (GMcases = 8.2 μg/L, GMcontrols = 4.9 μg/L; p = 0.01), and lower urinary concentrations of monobenzyl phthalate (mBzP) (GMcases = 7.5 μg/g creatinine, GMcontrols = 11.7 μg/g creatinine; p = 0.02). Logistic regression, controlling for body mass index, age and race, identified an increased likelihood of PCOS in subjects with higher serum concentrations of PFOA and PFOS (adjusted-ORs = 5.8-6.9, p < 0.05), and with lower urine concentrations of mBzP and mono-n-butyl phthalate (mBP) (aORs = 0.14-0.25, p < 0.05). Our data suggest that PCOS case-patients may differ from controls in their environmental contaminant profile. PCOS subjects had higher serum concentrations of two PFCs, PFOA and PFOS, and lower urine concentrations of mBP and mBzP. Future studies are needed to confirm these preliminary findings and determine if these chemicals or their precursors may have a role in the pathogenesis of PCOS. Background: Polycystic Ovary Syndrome (PCOS) is an endocrine-metabolic disorder that affects approximately 6-10% of women of child-bearing age. Although preliminary studies suggest that certain pollutants may act as endocrine disruptors in animals, little is known about their potential association with PCOS. The objective of this case-control pilot study is to determine whether women with PCOS have higher concentrations of specific environmental contaminants compared to women who have not developed PCOS. Methods: Fifty-two PCOS case-patients (diagnosed using the National Institutes of Health 1990 definition) and 50 controls were recruited in 2007-2008, from an urban academic medical center in Los Angeles, CA. Brominated diphenyl ethers, polychlorinated biphenyls (PCBs), organochlorine pesticides, and perfluorinated compounds (PFCs) were measured in serum, and phthalates metabolites and bisphenol A (BPA) in urine. Results: PCOS case-patients had significantly higher geometric mean (GM) serum concentrations of two PFCs: perfluorooctanoate (PFOA) (GM sub(cases) = 4.1 [mu]g/L, GM sub(controls) = 2.3 [mu]g/L; p = 0.001) and perfluorooctane sulfonate (PFOS) (GM sub(cases) = 8.2 [mu]g/L, GM sub(controls) = 4.9 [mu]g/L; p = 0.01), and lower urinary concentrations of monobenzyl phthalate (mBzP) (GM sub(cases) = 7.5 [mu]g/g creatinine, GM sub(controls) = 11.7 [mu]g/g creatinine; p = 0.02). Logistic regression, controlling for body mass index, age and race, identified an increased likelihood of PCOS in subjects with higher serum concentrations of PFOA and PFOS (adjusted-ORs = 5.8-6.9, p < 0.05), and with lower urine concentrations of mBzP and mono-n-butyl phthalate (mBP) (aORs = 0.14-0.25, p < 0.05). Conclusions: Our data suggest that PCOS case-patients may differ from controls in their environmental contaminant profile. PCOS subjects had higher serum concentrations of two PFCs, PFOA and PFOS, and lower urine concentrations of mBP and mBzP. Future studies are needed to confirm these preliminary findings and determine if these chemicals or their precursors may have a role in the pathogenesis of PCOS. |
| ArticleNumber | 86 |
| Audience | Academic |
| Author | Dumesic, Daniel Azziz-Baumgartner, Eduardo Ye, Xiaoyun Vagi, Sara J Calafat, Antonia M Sjödin, Andreas Kato, Kayoko Gonzalez, Leonardo Silva, Manori J Azziz, Ricardo |
| Author_xml | – sequence: 1 givenname: Sara J surname: Vagi fullname: Vagi, Sara J organization: U.S. Centers for Disease Control and Prevention – sequence: 2 givenname: Eduardo surname: Azziz-Baumgartner fullname: Azziz-Baumgartner, Eduardo organization: U.S. Centers for Disease Control and Prevention – sequence: 3 givenname: Andreas surname: Sjödin fullname: Sjödin, Andreas organization: U.S. Centers for Disease Control and Prevention – sequence: 4 givenname: Antonia M surname: Calafat fullname: Calafat, Antonia M organization: U.S. Centers for Disease Control and Prevention – sequence: 5 givenname: Daniel surname: Dumesic fullname: Dumesic, Daniel organization: University of California – sequence: 6 givenname: Leonardo surname: Gonzalez fullname: Gonzalez, Leonardo organization: Cedars Sinai Medical Center – sequence: 7 givenname: Kayoko surname: Kato fullname: Kato, Kayoko organization: U.S. Centers for Disease Control and Prevention – sequence: 8 givenname: Manori J surname: Silva fullname: Silva, Manori J organization: U.S. Centers for Disease Control and Prevention – sequence: 9 givenname: Xiaoyun surname: Ye fullname: Ye, Xiaoyun organization: U.S. Centers for Disease Control and Prevention – sequence: 10 givenname: Ricardo surname: Azziz fullname: Azziz, Ricardo email: razziz@gru.edu organization: University of California, Cedars Sinai Medical Center, Georgia Regents University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25348326$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNU8tu1DAUjVARfcCaHYrEhgXTOnFiOyyQqqo8pEpsYG157JsZVx472ElLdvwDf8iKz-BmZminFaAqC1v3nnN8fY5zmO354CHLnhfkuCgEOykqXs6YKOmsqGaCPcoObip7O_v97DClS0IKLkryJNsva1oJWrKD7Nf5t86FaP0i75eQd6EH31vlcpVS0Fb1Nvh8Dv01AK4xrKxXPZjc2G4JfnQ5IC2m18h0o16updaA-RaArRAXyodtE8-A1FttDUwsiK0bbkg6rLoweDN1lv1SOaziXvlJL02CASfLrd8cN05CebhScczT6A2OB2-wr1WCn99_6OD7iITUD2Z8mj1ulUvwbLseZV_enX8--zC7-PT-49npxUyzUvQzRQRAww3hTQt6TkStRSNoS8tCG1MWHEvMlGbezAvDCeGc06bVtGg0EC4qepSRje7gOzVeK-dkF-0KR5QFkVNocopFTrHgTgqGlLcbSjfMV2A0JhDVLS0oK-92vF3KRbiSVSk4pQ0KvNoKxPB1QHvlyiYNzikPYUiyYHXFGOM1fQCU1ngrwSbVl_egl2GIHs1boygXhNFb1EI5kNa3AUfUk6g8rWlTo3nVdMXjv6DwM7CymBO0Fut3CC92Pbkx48_LRcDJBqBjSClC-wCb63sMbfv1A8dZrPsPb5to6qb_BOKOD_-g_AY0MSaz |
| CitedBy_id | crossref_primary_10_3390_toxics12020104 crossref_primary_10_1016_j_beem_2021_101552 crossref_primary_10_1016_j_envpol_2019_01_039 crossref_primary_10_1177_25148486231192096 crossref_primary_10_3390_jox14020038 crossref_primary_10_1016_j_tox_2021_153031 crossref_primary_10_1111_joim_13748 crossref_primary_10_1007_s11356_016_7573_5 crossref_primary_10_1289_EHP12783 crossref_primary_10_3389_fendo_2015_00008 crossref_primary_10_1371_journal_pone_0120070 crossref_primary_10_1515_reveh_2022_0187 crossref_primary_10_1515_reveh_2020_0032 crossref_primary_10_3390_toxics12080539 crossref_primary_10_1016_j_fct_2018_06_011 crossref_primary_10_3390_cells12010174 crossref_primary_10_3390_ijerph19031257 crossref_primary_10_1007_s13668_024_00557_5 crossref_primary_10_1016_j_reprotox_2021_06_005 crossref_primary_10_1097_GRF_0000000000000562 crossref_primary_10_1016_j_reprotox_2023_108388 crossref_primary_10_3390_ijms23095176 crossref_primary_10_1007_s00204_020_02834_y crossref_primary_10_3389_fpubh_2020_553850 crossref_primary_10_1007_s11356_021_15204_7 crossref_primary_10_33920_med_10_2502_07 crossref_primary_10_1007_s40618_022_01885_5 crossref_primary_10_1016_j_envpol_2023_121957 crossref_primary_10_1021_acs_est_4c08701 crossref_primary_10_1093_molehr_gaab003 crossref_primary_10_5468_ogs_2020_63_1_1 crossref_primary_10_1016_j_envpol_2020_115962 crossref_primary_10_1097_MED_0000000000000309 crossref_primary_10_1002_jssc_201901223 crossref_primary_10_1016_j_ddmod_2020_11_008 crossref_primary_10_1016_j_envres_2016_07_011 crossref_primary_10_1016_j_ecoenv_2024_116251 crossref_primary_10_1186_s12958_023_01056_y crossref_primary_10_3390_ijerph19095608 crossref_primary_10_1080_03007995_2020_1729108 crossref_primary_10_1016_j_ecoenv_2022_113909 crossref_primary_10_1002_ijgo_15349 crossref_primary_10_1007_s11270_018_3796_z crossref_primary_10_1016_j_envpol_2022_120711 crossref_primary_10_3390_jcm11237227 crossref_primary_10_2903_j_efsa_2023_6857 crossref_primary_10_1080_26896583_2022_2043135 crossref_primary_10_1016_j_envint_2021_106819 crossref_primary_10_3390_ijms21197054 crossref_primary_10_1007_s12403_022_00496_y crossref_primary_10_1016_j_jsbmb_2022_106195 crossref_primary_10_38053_acmj_955138 crossref_primary_10_1080_09513590_2017_1405931 crossref_primary_10_1016_j_scitotenv_2017_06_137 crossref_primary_10_1016_j_reprotox_2024_108562 crossref_primary_10_33549_physiolres_934521 crossref_primary_10_1177_17455057221117966 crossref_primary_10_1016_j_ando_2017_04_024 crossref_primary_10_1289_EHP11814 crossref_primary_10_1515_reveh_2016_0067 crossref_primary_10_1152_physrev_00023_2015 crossref_primary_10_1016_j_cca_2023_117225 crossref_primary_10_1177_1933719116654992 crossref_primary_10_1515_hmbci_2020_0032 crossref_primary_10_1016_j_envres_2021_112584 crossref_primary_10_3390_ijms21093215 crossref_primary_10_1016_j_envint_2021_106837 crossref_primary_10_1055_s_0043_107242 crossref_primary_10_1016_j_envres_2020_109963 crossref_primary_10_4103_ijmr_IJMR_2077_16 crossref_primary_10_1016_j_etap_2023_104233 crossref_primary_10_1016_j_reprotox_2022_02_006 crossref_primary_10_1016_j_reprotox_2018_06_005 crossref_primary_10_1055_s_0043_104530 crossref_primary_10_1016_j_chemosphere_2021_131495 crossref_primary_10_1016_j_envint_2016_09_013 crossref_primary_10_3390_toxics12090678 crossref_primary_10_1016_j_fertnstert_2016_08_031 crossref_primary_10_1016_j_jsbmb_2024_106641 crossref_primary_10_1530_JME_18_0079 crossref_primary_10_1080_09513590_2019_1630608 crossref_primary_10_3390_biomedicines12061255 crossref_primary_10_1097_MD_0000000000016948 crossref_primary_10_1007_s00103_018_2709_z crossref_primary_10_1016_S2213_8587_20_30129_7 crossref_primary_10_1007_s11356_021_16489_4 crossref_primary_10_1016_j_fertnstert_2016_05_011 crossref_primary_10_3390_ijerph21121615 crossref_primary_10_4103_pjog_pjog_50_24 crossref_primary_10_1016_j_chemosphere_2023_138877 crossref_primary_10_1093_toxsci_kfac006 crossref_primary_10_3390_jcm12041454 crossref_primary_10_1007_s11356_022_21612_0 crossref_primary_10_1186_s12958_018_0448_5 crossref_primary_10_1055_s_0043_119751 crossref_primary_10_1016_j_envres_2024_118966 crossref_primary_10_1007_s12595_021_00406_1 crossref_primary_10_3390_life13010138 crossref_primary_10_1016_j_scitotenv_2024_175313 crossref_primary_10_1016_j_lfs_2019_116911 crossref_primary_10_1016_j_reprotox_2023_108515 crossref_primary_10_1016_j_yrtph_2021_104862 crossref_primary_10_3390_children6080089 crossref_primary_10_1055_s_0044_1801405 crossref_primary_10_2903_j_efsa_2024_8497 crossref_primary_10_1016_j_fertnstert_2015_01_005 crossref_primary_10_1016_j_ijheh_2018_07_009 crossref_primary_10_1016_j_pestbp_2023_105521 |
| Cites_doi | 10.2203/dose-response.003.03.002 10.1080/1047322X.1990.10389587 10.1097/EDE.0b013e31823b5031 10.1210/jc.2003-032046 10.1016/j.reprotox.2011.01.004 10.1210/jc.2010-1658 10.1210/jc.2010-2401 10.1002/jat.1672 10.1016/S0301-2115(01)00441-9 10.1021/ac050390d 10.1289/ehp.0901584 10.1093/humrep/der450 10.1093/humupd/8.3.231 10.1021/ac050671l 10.1016/j.jchromb.2007.10.023 10.1093/humrep/den490 10.1210/jc.2005-0628 10.1111/j.1365-2605.2012.01260.x 10.3109/09513598709023610 10.1146/annurev-physiol-012110-142200 10.1016/j.jsbmb.2004.12.008 10.1210/jc.2003-031122 10.1073/pnas.1207854109 10.1093/toxsci/58.2.339 10.1016/j.mce.2009.02.021 10.1210/jcem.84.11.6148 10.1021/ac030381+ 10.1002/sim.4780141908 10.1289/ehp.1205113 10.1507/endocrj.51.165 |
| ContentType | Journal Article |
| Copyright | Vagi et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( ) applies to the data made available in this article, unless otherwise stated. COPYRIGHT 2014 BioMed Central Ltd. 2014 Vagi et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Vagi et al.; licensee BioMed Central Ltd. 2014 |
| Copyright_xml | – notice: Vagi et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( ) applies to the data made available in this article, unless otherwise stated. – notice: COPYRIGHT 2014 BioMed Central Ltd. – notice: 2014 Vagi et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. – notice: Vagi et al.; licensee BioMed Central Ltd. 2014 |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7TK 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 7TV C1K 5PM ADTOC UNPAY |
| DOI | 10.1186/1472-6823-14-86 |
| DatabaseName | Springer Nature OA Free Journals (WRLC) CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Pollution Abstracts Environmental Sciences and Pollution Management PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic Pollution Abstracts Environmental Sciences and Pollution Management |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE Pollution Abstracts |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 5 dbid: BENPR name: Proquest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1472-6823 |
| EndPage | 86 |
| ExternalDocumentID | 10.1186/1472-6823-14-86 PMC4287339 3524617401 A539598346 25348326 10_1186_1472_6823_14_86 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | United States Los Angeles California United States--US USA, California, Los Angeles |
| GeographicLocations_xml | – name: United States – name: Los Angeles California – name: United States--US – name: USA, California, Los Angeles |
| GroupedDBID | --- 0R~ 23N 2WC 4.4 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK E3Z EBD EBLON EBS EJD ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH INR IPNFZ ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RIG RNS ROL RPM RSV SMD SOJ TR2 TUS UKHRP W2D WOQ WOW XSB ~8M AAYXX CITATION -A0 3V. ACRMQ ADINQ ALIPV C24 CGR CUY CVF ECM EIF NPM 7QP 7TK 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 7TV C1K 5PM 2VQ ADTOC AFFHD C1A UNPAY |
| ID | FETCH-LOGICAL-c628t-a08ee97d079fecb085c8983f321cdd217b086d2db9b1d70077739fc319ce07843 |
| IEDL.DBID | M48 |
| ISSN | 1472-6823 |
| IngestDate | Wed Oct 29 11:38:54 EDT 2025 Tue Sep 30 16:59:03 EDT 2025 Tue Oct 07 08:00:08 EDT 2025 Thu Oct 02 10:52:45 EDT 2025 Tue Oct 07 05:13:09 EDT 2025 Mon Oct 20 22:49:31 EDT 2025 Mon Oct 20 17:03:48 EDT 2025 Thu Jan 02 22:21:44 EST 2025 Wed Oct 01 02:40:01 EDT 2025 Thu Apr 24 23:08:34 EDT 2025 Sat Sep 06 07:23:16 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Polycystic Ovary Syndrome Phthalate Organochlorine Pesticide Indoor Dust PCOS Patient |
| Language | English |
| License | This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. cc-by |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c628t-a08ee97d079fecb085c8983f321cdd217b086d2db9b1d70077739fc319ce07843 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/1472-6823-14-86 |
| PMID | 25348326 |
| PQID | 1635378063 |
| PQPubID | 44656 |
| PageCount | 1 |
| ParticipantIDs | unpaywall_primary_10_1186_1472_6823_14_86 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4287339 proquest_miscellaneous_1654666753 proquest_miscellaneous_1635007869 proquest_journals_1635378063 gale_infotracmisc_A539598346 gale_infotracacademiconefile_A539598346 pubmed_primary_25348326 crossref_primary_10_1186_1472_6823_14_86 crossref_citationtrail_10_1186_1472_6823_14_86 springer_journals_10_1186_1472_6823_14_86 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2014-10-28 |
| PublicationDateYYYYMMDD | 2014-10-28 |
| PublicationDate_xml | – month: 10 year: 2014 text: 2014-10-28 day: 28 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC endocrine disorders |
| PublicationTitleAbbrev | BMC Endocr Disord |
| PublicationTitleAlternate | BMC Endocr Disord |
| PublicationYear | 2014 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V |
| References | Whitworth, Haug, Baird, Becher, Hoppin, Skjaerven, Thomsen, Eggesbo, Travlos, Wilson, Longnecker (CR27) 2012; 23 Fei, McLaughlin, Lipworth, Olsen (CR25) 2009; 24 Donato, Zani (CR30) 2010; 22 Silva, Samandar, Preau, Reidy, Needham, Calafat (CR19) 2007; 860 Knox, Jackson, Javins, Frisbee, Shankar, Ducatman (CR23) 2011; 96 Kuklenyik, Needham, Calafat (CR18) 2005; 77 Casals-Casas, Desvergne (CR13) 2011; 73 Azziz, Marin, Hoq, Badamgarav, Song (CR7) 2005; 90 Kodavanti (CR10) 2005; 3 Hines, White, Stanko, Gibbs-Flournoy, Lau, Fenton (CR14) 2009; 304 Tsutsumi (CR34) 2005; 93 Asuncion, Calvo, San Millan, Sancho, Avila, Escobar-Morreale (CR1) 2000; 85 Hull (CR5) 1987; 1 Parks, Ostby, Lambright, Abbott, Klinefelter, Barlow, Gray (CR12) 2000; 58 Hornung RW (CR21) 1990; 5 Kandaraki, Chatzigeorgiou, Livadas, Palioura, Economou, Koutsilieris, Palimeri, Panidis, Diamanti-Kandarakis (CR33) 2011; 96 Hunt, Lawson, Gieske, Murdoch, Smith, Marre, Hassold, VandeVoort (CR11) 2012; 109 Wild (CR6) 2002; 8 Azziz, Sanchez, Knochenhauer, Moran, Lazenby, Stephens, Taylor, Boots (CR16) 2004; 89 Recio-Vega, Velazco-Rodriguez, Ocampo-Gomez, Hernandez-Gonzalez, Ruiz-Flores, Lopez-Marquez (CR29) 2011; 31 Shelby (CR9) 2008; 22 Cohn, Cirillo, Sholtz, Ferrara, Park, Schwingl (CR28) 2011; 31 Sjodin, Jones, Lapeza, Focant, McGahee, Patterson (CR17) 2004; 76 Ye, Kuklenyik, Needham, Calafat (CR20) 2005; 77 Frederiksen, Sorensen, Mouritsen, Aksglaede, Hagen, Petersen, Skakkebaek, Andersson, Juul (CR32) 2012; 35 Massaad, Entezami, Massade, Benahmed, Olivennes, Barouki, Hamamah (CR8) 2002; 100 Takeuchi, Tsutsumi, Ikezuki, Takai, Taketani (CR35) 2004; 51 Prevention (CR15) 2012 Azziz, Woods, Reyna, Key, Knochenhauer, Yildiz (CR2) 2004; 89 Joensen, Frederiksen, Jensen, Lauritsen, Olesen, Lassen, Andersson, Jorgensen (CR31) 2012; 120 Knochenhauer, Key, Kahsar-Miller, Waggoner, Boots, Azziz (CR4) 1998; 83 (CR36) 2010 Vestergaard, Nielsen, Andersson, Hjollund, Grandjean, Andersen, Jensen (CR26) 2012; 27 Mehta, Patel (CR22) 1995; 14 Diamanti-Kandarakis, Kouli, Bergiele, Filandra, Tsianateli, Spina, Zapanti, Bartzis (CR3) 1999; 84 Melzer, Rice, Depledge, Henley, Galloway (CR24) 2010; 118 CDC (298_CR15) 2012 UN Joensen (298_CR31) 2012; 120 E Diamanti-Kandarakis (298_CR3) 1999; 84 R Azziz (298_CR7) 2005; 90 C Fei (298_CR25) 2009; 24 RA Wild (298_CR6) 2002; 8 SS Knox (298_CR23) 2011; 96 WHO (World Health Organization) (298_CR36) 2010 RL Hornung RW (298_CR21) 1990; 5 R Azziz (298_CR16) 2004; 89 CR Mehta (298_CR22) 1995; 14 X Ye (298_CR20) 2005; 77 F Donato (298_CR30) 2010; 22 C Casals-Casas (298_CR13) 2011; 73 R Recio-Vega (298_CR29) 2011; 31 Z Kuklenyik (298_CR18) 2005; 77 H Frederiksen (298_CR32) 2012; 35 T Takeuchi (298_CR35) 2004; 51 BA Cohn (298_CR28) 2011; 31 M Asuncion (298_CR1) 2000; 85 C Massaad (298_CR8) 2002; 100 LG Parks (298_CR12) 2000; 58 MD Shelby (298_CR9) 2008; 22 O Tsutsumi (298_CR34) 2005; 93 PA Hunt (298_CR11) 2012; 109 ES Knochenhauer (298_CR4) 1998; 83 R Azziz (298_CR2) 2004; 89 E Kandaraki (298_CR33) 2011; 96 A Sjodin (298_CR17) 2004; 76 EP Hines (298_CR14) 2009; 304 S Vestergaard (298_CR26) 2012; 27 MJ Silva (298_CR19) 2007; 860 D Melzer (298_CR24) 2010; 118 MG Hull (298_CR5) 1987; 1 PR Kodavanti (298_CR10) 2005; 3 KW Whitworth (298_CR27) 2012; 23 17997365 - J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Dec 1;860(1):106-12 22246448 - Hum Reprod. 2012 Mar;27(3):873-80 21193545 - J Clin Endocrinol Metab. 2011 Mar;96(3):E480-4 11750951 - Eur J Obstet Gynecol Reprod Biol. 2002 Jan 10;100(2):127-37 21054169 - Annu Rev Physiol. 2011;73:135-62 21411548 - J Clin Endocrinol Metab. 2011 Jun;96(6):1747-53 16159145 - Anal Chem. 2005 Sep 15;77(18):6085-91 15944216 - J Clin Endocrinol Metab. 2005 Aug;90(8):4650-8 19407859 - NTP CERHR MON. 2008 Sep;(22):v, vii-ix, 1-64 passim 10566641 - J Clin Endocrinol Metab. 1999 Nov;84(11):4006-11 16097788 - Anal Chem. 2005 Aug 15;77(16):5407-13 10902790 - J Clin Endocrinol Metab. 2000 Jul;85(7):2434-8 21480306 - J Appl Toxicol. 2011 Apr;31(3):270-8 19176540 - Hum Reprod. 2009 May;24(5):1200-5 22081060 - Epidemiology. 2012 Mar;23(2):257-63 20089479 - Environ Health Perspect. 2010 May;118(5):686-92 15053652 - Anal Chem. 2004 Apr 1;76(7):1921-7 3140583 - Gynecol Endocrinol. 1987 Sep;1(3):235-45 22428786 - Int J Androl. 2012 Jun;35(3):216-26 21296657 - Reprod Toxicol. 2011 Apr;31(3):290-6 22832070 - Environ Health Perspect. 2012 Oct;120(10):1397-403 18648619 - Dose Response. 2006 May 01;3(3):273-305 15181052 - J Clin Endocrinol Metab. 2004 Jun;89(6):2745-9 15118266 - Endocr J. 2004 Apr;51(2):165-9 9745406 - J Clin Endocrinol Metab. 1998 Sep;83(9):3078-82 19433254 - Mol Cell Endocrinol. 2009 May 25;304(1-2):97-105 14764747 - J Clin Endocrinol Metab. 2004 Feb;89(2):453-62 12078834 - Hum Reprod Update. 2002 May-Jun;8(3):231-41 20677670 - Ann Ig. 2010 May-Jun;22(3):185-98 8552893 - Stat Med. 1995 Oct 15;14(19):2143-60 11099646 - Toxicol Sci. 2000 Dec;58(2):339-49 15860277 - J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):325-30 23012422 - Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17525-30 |
| References_xml | – volume: 85 start-page: 2434 issue: 7 year: 2000 end-page: 2438 ident: CR1 article-title: A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain publication-title: J Clin Endocrinol Metab – volume: 3 start-page: 273 issue: 3 year: 2005 end-page: 305 ident: CR10 article-title: Neurotoxicity of persistent organic pollutants: possible mode(s) of action and further considerations publication-title: Dose Response doi: 10.2203/dose-response.003.03.002 – volume: 5 start-page: 46 issue: 1 year: 1990 end-page: 51 ident: CR21 article-title: Estimation of average concentration in the presence of nondetectable values publication-title: Appl Occup Environ Hyg doi: 10.1080/1047322X.1990.10389587 – volume: 23 start-page: 257 issue: 2 year: 2012 end-page: 263 ident: CR27 article-title: Perfluorinated compounds and subfecundity in pregnant women publication-title: Epidemiology doi: 10.1097/EDE.0b013e31823b5031 – volume: 22 start-page: 185 issue: 3 year: 2010 end-page: 198 ident: CR30 article-title: [Chronic exposure to organochlorine compounds and health effects in adults: diabetes and thyroid diseases] publication-title: Ann Ig – volume: 89 start-page: 2745 issue: 6 year: 2004 end-page: 2749 ident: CR2 article-title: The prevalence and features of the polycystic ovary syndrome in an unselected population publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2003-032046 – volume: 31 start-page: 290 issue: 3 year: 2011 end-page: 296 ident: CR28 article-title: Polychlorinated biphenyl (PCB) exposure in mothers and time to pregnancy in daughters publication-title: Reprod Toxicol doi: 10.1016/j.reprotox.2011.01.004 – volume: 96 start-page: E480 issue: 3 year: 2011 end-page: 484 ident: CR33 article-title: Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2010-1658 – volume: 96 start-page: 1747 issue: 6 year: 2011 end-page: 1753 ident: CR23 article-title: Implications of early menopause in women exposed to perfluorocarbons publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2010-2401 – volume: 31 start-page: 270 issue: 3 year: 2011 end-page: 278 ident: CR29 article-title: Serum levels of polychlorinated biphenyls in Mexican women and breast cancer risk publication-title: J Appl Toxicol doi: 10.1002/jat.1672 – volume: 100 start-page: 127 issue: 2 year: 2002 end-page: 137 ident: CR8 article-title: How can chemical compounds alter human fertility? publication-title: Eur J Obstet Gynecol Reprod Biol doi: 10.1016/S0301-2115(01)00441-9 – volume: 83 start-page: 3078 issue: 9 year: 1998 end-page: 3082 ident: CR4 article-title: Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study publication-title: J Clin Endocrinol Metab – volume: 77 start-page: 5407 issue: 16 year: 2005 end-page: 5413 ident: CR20 article-title: Automated on-line column-switching HPLC-MS/MS method with peak focusing for the determination of nine environmental phenols in urine publication-title: Anal Chem doi: 10.1021/ac050390d – volume: 118 start-page: 686 issue: 5 year: 2010 end-page: 692 ident: CR24 article-title: Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey publication-title: Environ Health Perspect doi: 10.1289/ehp.0901584 – volume: 27 start-page: 873 issue: 3 year: 2012 end-page: 880 ident: CR26 article-title: Association between perfluorinated compounds and time to pregnancy in a prospective cohort of Danish couples attempting to conceive publication-title: Hum Reprod doi: 10.1093/humrep/der450 – volume: 8 start-page: 231 issue: 3 year: 2002 end-page: 241 ident: CR6 article-title: Long-term health consequences of PCOS publication-title: Hum Reprod Update doi: 10.1093/humupd/8.3.231 – volume: 77 start-page: 6085 issue: 18 year: 2005 end-page: 6091 ident: CR18 article-title: Measurement of 18 perfluorinated organic acids and amides in human serum using on-line solid-phase extraction publication-title: Anal Chem doi: 10.1021/ac050671l – volume: 860 start-page: 106 issue: 1 year: 2007 end-page: 112 ident: CR19 article-title: Quantification of 22 phthalate metabolites in human urine publication-title: J Chromatogr B Analyt Technol Biomed Life Sci doi: 10.1016/j.jchromb.2007.10.023 – volume: 24 start-page: 1200 issue: 5 year: 2009 end-page: 1205 ident: CR25 article-title: Maternal levels of perfluorinated chemicals and subfecundity publication-title: Hum Reprod doi: 10.1093/humrep/den490 – volume: 90 start-page: 4650 issue: 8 year: 2005 end-page: 4658 ident: CR7 article-title: Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2005-0628 – volume: 35 start-page: 216 issue: 3 year: 2012 end-page: 226 ident: CR32 article-title: High urinary phthalate concentration associated with delayed pubarche in girls publication-title: Int J Androl doi: 10.1111/j.1365-2605.2012.01260.x – year: 2010 ident: CR36 publication-title: Joint FAO/WHO Expert Meeting to Review Toxicological and Health Aspects of Bisphenol A: Summary Report including Report of Stakeholders Meeting on Bisphenol A – volume: 1 start-page: 235 issue: 3 year: 1987 end-page: 245 ident: CR5 article-title: Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies publication-title: Gynecol Endocrinol doi: 10.3109/09513598709023610 – volume: 73 start-page: 135 year: 2011 end-page: 162 ident: CR13 article-title: Endocrine disruptors: from endocrine to metabolic disruption publication-title: Annu Rev Physiol doi: 10.1146/annurev-physiol-012110-142200 – volume: 93 start-page: 325 issue: 2–5 year: 2005 end-page: 330 ident: CR34 article-title: Assessment of human contamination of estrogenic endocrine-disrupting chemicals and their risk for human reproduction publication-title: J Steroid Biochem Mol Biol doi: 10.1016/j.jsbmb.2004.12.008 – volume: 22 start-page: 1 year: 2008 end-page: 64 passim ident: CR9 article-title: NTP-CERHR monograph on the potential human reproductive and developmental effects of bisphenol A publication-title: Ntp Cerhr Mon – volume: 89 start-page: 453 issue: 2 year: 2004 end-page: 462 ident: CR16 article-title: Androgen excess in women: experience with over 1000 consecutive patients publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2003-031122 – volume: 109 start-page: 17525 issue: 43 year: 2012 end-page: 17530 ident: CR11 article-title: Bisphenol A alters early oogenesis and follicle formation in the fetal ovary of the rhesus monkey publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1207854109 – volume: 58 start-page: 339 issue: 2 year: 2000 end-page: 349 ident: CR12 article-title: The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat publication-title: Toxicol Sci doi: 10.1093/toxsci/58.2.339 – volume: 304 start-page: 97 issue: 1–2 year: 2009 end-page: 105 ident: CR14 article-title: Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: Low doses induce elevated serum leptin and insulin, and overweight in mid-life publication-title: Mol Cell Endocrinol doi: 10.1016/j.mce.2009.02.021 – volume: 84 start-page: 4006 issue: 11 year: 1999 end-page: 4011 ident: CR3 article-title: A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem.84.11.6148 – volume: 76 start-page: 1921 issue: 7 year: 2004 end-page: 1927 ident: CR17 article-title: Semiautomated high-throughput extraction and cleanup method for the measurement of polybrominated diphenyl ethers, polybrominated biphenyls, and polychlorinated biphenyls in human serum publication-title: Anal Chem doi: 10.1021/ac030381+ – volume: 14 start-page: 2143 issue: 19 year: 1995 end-page: 2160 ident: CR22 article-title: Exact logistic regression: theory and examples publication-title: Stat Med doi: 10.1002/sim.4780141908 – volume: 120 start-page: 1397 issue: 10 year: 2012 end-page: 1403 ident: CR31 article-title: Phthalate excretion pattern and testicular function: a study of 881 healthy Danish men publication-title: Environ Health Perspect doi: 10.1289/ehp.1205113 – year: 2012 ident: CR15 publication-title: Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables – volume: 51 start-page: 165 issue: 2 year: 2004 end-page: 169 ident: CR35 article-title: Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction publication-title: Endocr J doi: 10.1507/endocrj.51.165 – volume: 84 start-page: 4006 issue: 11 year: 1999 ident: 298_CR3 publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem.84.11.6148 – volume: 76 start-page: 1921 issue: 7 year: 2004 ident: 298_CR17 publication-title: Anal Chem doi: 10.1021/ac030381+ – volume: 109 start-page: 17525 issue: 43 year: 2012 ident: 298_CR11 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1207854109 – volume: 90 start-page: 4650 issue: 8 year: 2005 ident: 298_CR7 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2005-0628 – volume: 8 start-page: 231 issue: 3 year: 2002 ident: 298_CR6 publication-title: Hum Reprod Update doi: 10.1093/humupd/8.3.231 – volume: 77 start-page: 6085 issue: 18 year: 2005 ident: 298_CR18 publication-title: Anal Chem doi: 10.1021/ac050671l – volume: 31 start-page: 290 issue: 3 year: 2011 ident: 298_CR28 publication-title: Reprod Toxicol doi: 10.1016/j.reprotox.2011.01.004 – volume: 35 start-page: 216 issue: 3 year: 2012 ident: 298_CR32 publication-title: Int J Androl doi: 10.1111/j.1365-2605.2012.01260.x – volume: 89 start-page: 2745 issue: 6 year: 2004 ident: 298_CR2 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2003-032046 – volume: 22 start-page: 1 year: 2008 ident: 298_CR9 publication-title: Ntp Cerhr Mon – volume: 77 start-page: 5407 issue: 16 year: 2005 ident: 298_CR20 publication-title: Anal Chem doi: 10.1021/ac050390d – volume: 93 start-page: 325 issue: 2–5 year: 2005 ident: 298_CR34 publication-title: J Steroid Biochem Mol Biol doi: 10.1016/j.jsbmb.2004.12.008 – volume: 5 start-page: 46 issue: 1 year: 1990 ident: 298_CR21 publication-title: Appl Occup Environ Hyg doi: 10.1080/1047322X.1990.10389587 – volume: 23 start-page: 257 issue: 2 year: 2012 ident: 298_CR27 publication-title: Epidemiology doi: 10.1097/EDE.0b013e31823b5031 – volume: 304 start-page: 97 issue: 1–2 year: 2009 ident: 298_CR14 publication-title: Mol Cell Endocrinol doi: 10.1016/j.mce.2009.02.021 – volume: 83 start-page: 3078 issue: 9 year: 1998 ident: 298_CR4 publication-title: J Clin Endocrinol Metab – volume: 100 start-page: 127 issue: 2 year: 2002 ident: 298_CR8 publication-title: Eur J Obstet Gynecol Reprod Biol doi: 10.1016/S0301-2115(01)00441-9 – volume: 96 start-page: 1747 issue: 6 year: 2011 ident: 298_CR23 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2010-2401 – volume: 24 start-page: 1200 issue: 5 year: 2009 ident: 298_CR25 publication-title: Hum Reprod doi: 10.1093/humrep/den490 – volume: 58 start-page: 339 issue: 2 year: 2000 ident: 298_CR12 publication-title: Toxicol Sci doi: 10.1093/toxsci/58.2.339 – volume: 118 start-page: 686 issue: 5 year: 2010 ident: 298_CR24 publication-title: Environ Health Perspect doi: 10.1289/ehp.0901584 – volume: 89 start-page: 453 issue: 2 year: 2004 ident: 298_CR16 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2003-031122 – volume-title: Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables year: 2012 ident: 298_CR15 – volume: 22 start-page: 185 issue: 3 year: 2010 ident: 298_CR30 publication-title: Ann Ig – volume: 14 start-page: 2143 issue: 19 year: 1995 ident: 298_CR22 publication-title: Stat Med doi: 10.1002/sim.4780141908 – volume: 27 start-page: 873 issue: 3 year: 2012 ident: 298_CR26 publication-title: Hum Reprod doi: 10.1093/humrep/der450 – volume: 3 start-page: 273 issue: 3 year: 2005 ident: 298_CR10 publication-title: Dose Response doi: 10.2203/dose-response.003.03.002 – volume: 31 start-page: 270 issue: 3 year: 2011 ident: 298_CR29 publication-title: J Appl Toxicol doi: 10.1002/jat.1672 – volume: 96 start-page: E480 issue: 3 year: 2011 ident: 298_CR33 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2010-1658 – volume: 73 start-page: 135 year: 2011 ident: 298_CR13 publication-title: Annu Rev Physiol doi: 10.1146/annurev-physiol-012110-142200 – volume-title: Joint FAO/WHO Expert Meeting to Review Toxicological and Health Aspects of Bisphenol A: Summary Report including Report of Stakeholders Meeting on Bisphenol A year: 2010 ident: 298_CR36 – volume: 120 start-page: 1397 issue: 10 year: 2012 ident: 298_CR31 publication-title: Environ Health Perspect doi: 10.1289/ehp.1205113 – volume: 51 start-page: 165 issue: 2 year: 2004 ident: 298_CR35 publication-title: Endocr J doi: 10.1507/endocrj.51.165 – volume: 1 start-page: 235 issue: 3 year: 1987 ident: 298_CR5 publication-title: Gynecol Endocrinol doi: 10.3109/09513598709023610 – volume: 860 start-page: 106 issue: 1 year: 2007 ident: 298_CR19 publication-title: J Chromatogr B Analyt Technol Biomed Life Sci doi: 10.1016/j.jchromb.2007.10.023 – volume: 85 start-page: 2434 issue: 7 year: 2000 ident: 298_CR1 publication-title: J Clin Endocrinol Metab – reference: 22832070 - Environ Health Perspect. 2012 Oct;120(10):1397-403 – reference: 19433254 - Mol Cell Endocrinol. 2009 May 25;304(1-2):97-105 – reference: 16097788 - Anal Chem. 2005 Aug 15;77(16):5407-13 – reference: 8552893 - Stat Med. 1995 Oct 15;14(19):2143-60 – reference: 19407859 - NTP CERHR MON. 2008 Sep;(22):v, vii-ix, 1-64 passim – reference: 22428786 - Int J Androl. 2012 Jun;35(3):216-26 – reference: 15860277 - J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):325-30 – reference: 19176540 - Hum Reprod. 2009 May;24(5):1200-5 – reference: 22246448 - Hum Reprod. 2012 Mar;27(3):873-80 – reference: 10566641 - J Clin Endocrinol Metab. 1999 Nov;84(11):4006-11 – reference: 11099646 - Toxicol Sci. 2000 Dec;58(2):339-49 – reference: 22081060 - Epidemiology. 2012 Mar;23(2):257-63 – reference: 15118266 - Endocr J. 2004 Apr;51(2):165-9 – reference: 21411548 - J Clin Endocrinol Metab. 2011 Jun;96(6):1747-53 – reference: 17997365 - J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Dec 1;860(1):106-12 – reference: 11750951 - Eur J Obstet Gynecol Reprod Biol. 2002 Jan 10;100(2):127-37 – reference: 16159145 - Anal Chem. 2005 Sep 15;77(18):6085-91 – reference: 14764747 - J Clin Endocrinol Metab. 2004 Feb;89(2):453-62 – reference: 15181052 - J Clin Endocrinol Metab. 2004 Jun;89(6):2745-9 – reference: 15053652 - Anal Chem. 2004 Apr 1;76(7):1921-7 – reference: 20089479 - Environ Health Perspect. 2010 May;118(5):686-92 – reference: 3140583 - Gynecol Endocrinol. 1987 Sep;1(3):235-45 – reference: 21296657 - Reprod Toxicol. 2011 Apr;31(3):290-6 – reference: 15944216 - J Clin Endocrinol Metab. 2005 Aug;90(8):4650-8 – reference: 18648619 - Dose Response. 2006 May 01;3(3):273-305 – reference: 21480306 - J Appl Toxicol. 2011 Apr;31(3):270-8 – reference: 20677670 - Ann Ig. 2010 May-Jun;22(3):185-98 – reference: 21193545 - J Clin Endocrinol Metab. 2011 Mar;96(3):E480-4 – reference: 12078834 - Hum Reprod Update. 2002 May-Jun;8(3):231-41 – reference: 9745406 - J Clin Endocrinol Metab. 1998 Sep;83(9):3078-82 – reference: 10902790 - J Clin Endocrinol Metab. 2000 Jul;85(7):2434-8 – reference: 21054169 - Annu Rev Physiol. 2011;73:135-62 – reference: 23012422 - Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17525-30 |
| SSID | ssj0017820 |
| Score | 2.383999 |
| Snippet | Background
Polycystic Ovary Syndrome (PCOS) is an endocrine-metabolic disorder that affects approximately 6-10% of women of child-bearing age. Although... Polycystic Ovary Syndrome (PCOS) is an endocrine-metabolic disorder that affects approximately 6-10% of women of child-bearing age. Although preliminary... Background Polycystic Ovary Syndrome (PCOS) is an endocrine-metabolic disorder that affects approximately 6-10% of women of child-bearing age. Although... Doc number: 86 Abstract Background: Polycystic Ovary Syndrome (PCOS) is an endocrine-metabolic disorder that affects approximately 6-10% of women of... Background: Polycystic Ovary Syndrome (PCOS) is an endocrine-metabolic disorder that affects approximately 6-10% of women of child-bearing age. Although... |
| SourceID | unpaywall pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 86 |
| SubjectTerms | Adolescent Adult Benzhydryl Compounds - blood Bisphenol A Caprylates - blood Care and treatment Case-Control Studies Chromatography, Gas Diabetes Diagnosis Disease control Endocrine disruptors Endocrine Disruptors - adverse effects Endocrine Disruptors - blood Endocrinology Environmental Monitoring Environmental Pollutants - adverse effects Environmental Pollutants - blood Epidemiology of Endocrine Disorders Female Fluorocarbons - blood Halogenated Diphenyl Ethers - blood Health aspects Humans Hydrocarbons, Chlorinated - blood Mass Spectrometry Medical centers Medicine Medicine & Public Health Metabolic Diseases Metabolites Middle Aged PCB Pesticides - blood Phenols - blood Phthalic Acids - blood Pilot Projects Polychlorinated biphenyls Polychlorinated Biphenyls - blood Polycystic ovary syndrome Polycystic Ovary Syndrome - blood Polycystic Ovary Syndrome - chemically induced Polycystic Ovary Syndrome - epidemiology Prevalence Research Article Risk factors rology Solid Phase Extraction Specimen Handling Stein-Leventhal syndrome Studies Type 2 diabetes United States - epidemiology |
| SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3ra9swEBddCnt8GHsvWzc0GGyFarUtWZYHY3SjpQwaxlih34xeJgFjZ3ls5B_e37E7R3aTQrtvIXd6WD6dfrJOvyPkbe6kT7XzzJSeM2G1Yyo1nGWRyQDMASbW-B3ybCRPz8W3i_Rih4y6uzAYVtn5xNZRu8biN_JDwA0pzxSsqJ-nvxhmjcLT1S6Fhg6pFdynlmLsFtlNkBlrQHa_HI--_-jPFZAdLhD8xEoexiJLmFQJZ7FgeJ16Y2266qE3lqir4ZP9Geo9cmdZT_Xqj66qjWXq5AG5H_AlPVobxEOy4-tH5PZZOEF_TP72QXcUoB-dNgsMF4IS-vI90RC8Rc2swUgZAKXUTTAYbFXR9oLw_ABKVuA626paBRMUQNRmimqCENpAIg87cR5L-VlZLftCGNCOeZ1QMl6MdYXI94DqGuubY4UN9IxO6nVzK6yINr_1bEU7qoWPILewFLMQdE9bwtwn5Pzk-OfXUxZyPTArE7VgOlLe55mLsrz01gAQtCpXvORJbJ2DfRP8JV3iTG5ilyEJUcbz0oIDsR5QjuBPyaBuav-c0CjWQibCSxtZoU2Sl0Z7FXErI6cUd0PyoXvLhQ1E6JiPoyraDZGSBZpFgWYBvwolh-R9X2C65gC5XvUdmk2B3gHqtDpccoCeIc9WcZTyPIXnEqC5t6UJs9puizvDK4JXmReXc2BI3vRiLImRcrVvlmsdxH0yv0knFbBthZ3qkDxb23L_YEnKBXh56EC2ZeW9AvKRb0vqybjlJcfdN-fQ7n43Hza6ft147fcT5n9j--LmIXlJ7gKYFYgrErVHBovZ0r8CwLgwr4MX-AdmZnAR priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals (WRLC) dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bi9QwFA66gpcH8e7oKhEEXdisbZOmqW_L4rII65ML-1ZyKzNQ2mGms8u8-R_8hz75MzynzdTp4iq-DXMuSdOT5Etz8oWQt7mTPtXOM1N6zoTVjqnUcJZFJgMwB5hY43fI0y_y5Ex8Pk_PA0kSnoXZ3r-PlfwQiyxhUiWcxYIpeZPcghlKdruy8mjYLkDSt8Db8wej0ZRzdeDdmnmuZkUOW6P3yJ1VPdfrS11VW7PP8QNyP8BGeti_54fkhq8fkdunYWP8Mfk55NJRQHR03rSYBQQW-nfz05CTRc2iwQQYwJrUzTDHa13R7tzvch8sKxgRO1edggkKIOougGqCEMpAfg47cx6t_KKsVoMR5qnjdU0ombZTXSGg3ae6Rn9LdNhAzeis7otboyPaXOjFmm4YFD6C3MIM--Pb95BNTzsm3Cfk7PjT16MTFi5xYFYmqmU6Ut7nmYuyvPTWAMKzKle85ElsnYMFEfwlXeJMbmKXIbtQxvPSwshgPcAXwZ-Snbqp_XNCo1gLmQgvbWSFNkleGu1VxK2MnFLcTcjB5j0XNjCc40UbVdGtdJQsMDAKDAz4VSg5Ie8Hg3lP7nG96jsMnAK7Pfi0OpxegJohgVZxmPI8hecSoLk70oTuasfiTegVYbhYFgCKU54pgIsT8mYQoyWmwNW-WfU6COhk_jedVMB6FJagE_Ksj-bhwZKUCxi-oQLZKM4HBSQaH0vq2bQjHMdlNedQ7t6mR2xV_br22hu6zL_a9sV_-H1J7gJkFYgeErVLdtrFyr8CWNia192Q8AtZz2KN priority: 102 providerName: Springer Nature – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bi9NAFB7WLnh58H6prjKCoAubbppJJhPfirgsQhcfLKxPYW6hxZiUNFXqk__Bf-iTP8Nzkmlsi6sIvoWcc-aSzJz5JjnnG0KeJYbbSBrrqcwyL9TSeCJSzIt9FQOYA0ws8Tvk-IyfTsI359H5Hhmvc2HUR20LU-rKNOSTg80k9LzNccAzFGx1PDdZO-UFPx6GceBxETBvGHqCXyL7PAJo3iP7k7O3o_dNhpHTcPQ-v7HaWpl2_fPGArUbPNn9Qb1GriyLuVx9lnm-sUid3CDFunttbMqHwbJWA_1lh_nxv_X_Jrnu4CwdtePvFtmzxW1yeex-2N8hP7oYPwpIk87LGqOTwEL-GhbUxYpRVZUYmAMYmJoZxp6tctrkIy-OwDIHT90U1SgopwCi5mCq0gmhDuQN0TNj0cpWWb7sjDB-Ho-RQsm0nsocgfYRlQWWt8ACS2gZnRVtdSssiJafZLWia2aHlyDXsPJ___rNRfnThqH3LpmcvH736tRzh0t4mgei9qQvrE1i48dJZrUC5KlFIljGgqE2BjZqcIubwKhEDU2MrEcxSzINHktbgFUhu0d6RVnYB4T6QxnyILRc-zqUKkgyJa3wmea-EYKZPhmsB1aqHfM6HgCSp80OTPAU31-K7w-uUsH75EVnMG9JRy5WfY4jNUV3BGVq6bIqoGVI7JWOIpZE0K8QNA-2NMGN6G3xeqynzo0tUgDrEYsFwNg-edqJ0RJD8wpbLlsdBJo8-ZNOFMI-GbbGfXK_nT5dx4KIhbCsQAPirYnVKSAB-rakmE0bInTc7jMG9R6up-BG0y96XofdHP3bs334D7qPyFWA0iGimkAckF5dLe1jgKu1euKc0E-qGZiT priority: 102 providerName: Unpaywall |
| Title | Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol a in polycystic ovary syndrome: a case–control study |
| URI | https://link.springer.com/article/10.1186/1472-6823-14-86 https://www.ncbi.nlm.nih.gov/pubmed/25348326 https://www.proquest.com/docview/1635378063 https://www.proquest.com/docview/1635007869 https://www.proquest.com/docview/1654666753 https://pubmed.ncbi.nlm.nih.gov/PMC4287339 https://bmcendocrdisord.biomedcentral.com/counter/pdf/10.1186/1472-6823-14-86 |
| UnpaywallVersion | publishedVersion |
| Volume | 14 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central Open Access Free customDbUrl: eissn: 1472-6823 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017820 issn: 1472-6823 databaseCode: RBZ dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1472-6823 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017820 issn: 1472-6823 databaseCode: KQ8 dateStart: 20011001 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1472-6823 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017820 issn: 1472-6823 databaseCode: KQ8 dateStart: 20010101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1472-6823 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017820 issn: 1472-6823 databaseCode: DOA dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1472-6823 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017820 issn: 1472-6823 databaseCode: ABDBF dateStart: 20010101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1472-6823 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017820 issn: 1472-6823 databaseCode: DIK dateStart: 20010101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1472-6823 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017820 issn: 1472-6823 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1472-6823 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017820 issn: 1472-6823 databaseCode: M~E dateStart: 20010101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1472-6823 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017820 issn: 1472-6823 databaseCode: RPM dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1472-6823 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017820 issn: 1472-6823 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Proquest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1472-6823 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017820 issn: 1472-6823 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1472-6823 dateEnd: 20250131 omitProxy: true ssIdentifier: ssj0017820 issn: 1472-6823 databaseCode: M48 dateStart: 20011001 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAVX databaseName: HAS SpringerNature Open Access 2022 customDbUrl: eissn: 1472-6823 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017820 issn: 1472-6823 databaseCode: AAJSJ dateStart: 20011201 isFulltext: true titleUrlDefault: https://www.springernature.com providerName: Springer Nature – providerCode: PRVAVX databaseName: Springer Nature OA Free Journals customDbUrl: eissn: 1472-6823 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017820 issn: 1472-6823 databaseCode: C6C dateStart: 20010112 isFulltext: true titleUrlDefault: http://www.springeropen.com/ providerName: Springer Nature |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fa9swEBdrC1v3MPava7YuaDDYCnXnWLIsD8ZIQ0sZJJSyQLYXI0syCRg7y59tedt32Dfc0z7G7hzbSUq7wV5CkruTZPlO-p11viPkZWiE9ZWxTpxY5nCtjCP9mDmBGwcA5gATK3wO2e2J8z7_MPAHq3JA5QROr3XtsJ5Uf5Ief_-yeA8G_64weCnetHjgOUJ6zGlxR4otsgPbVIh1HLp8daSAieHK3D7XCGFSYJ9x0G-xsUNdXafXNqqrQZT1SepdcmeejdXim0rTtc3q7D65V6JM2l6qxQNyy2YPye1ueY7-iPyuQ-8oAEA6zmcYNAQSanW3aBnCReNJjvEyAE2pGWFI2CKlxWvC0yOQTGEBLZoqGOKSAUhFvai8JEIfmM5Dj4xFKTtJ0nkthGHtWN0JKcPZUKWIf4-oyrC9KTaYw8joKFt2t8CGaP5VTRa0SrjwFugaNuRfP36Wwfe0SJz7mPTPTj92zp2y5oOjhSdnjnKltWFg3CBMrI4BEGoZSpYwr6WNAf8J_hLGM3EYt0yAyYgCFiYaFhJtAe1wtke2szyz-4S6LcWFx63QruYq9sIkVla6TAvXSMlMgxxX9znSZUJ0rMuRRoVjJEWEOhKhjsC3SIoGeV0LjJe5QG5mfYWKE6HeQptalS87wMgw31bU9lnow3Vx4DzY4ATr1pvkSvWiyjgiwNA-CySgywZ5UZNREiPmMpvPlzyI_0T4Nx6fg_sKHmuDPFlqc31hlTU0SLCh5zUD5iXfpGSjYZGfHL1wxqDfw8oi1oZ-03wd1ibzr7l9-t8jekZ2Ae9yhB6ePCDbs8ncPgdMOYubZCsYBE2yc3Lau7iEXx3RaRbPZ5rFKgKflyefgd7vXbQ__QGBEYIX |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELfGJjF4QPynMMBIIJg0szR2EgdpQgM2dWyt0LRJewuO7aiVoqT0D1O_HB-Hz8Fd6mTtpI2nvVW9s-PY57vfxec7Qt7GJrSBMpalmeVMaGWYDFLOIi-NAMwBJlb4HbLbCzun4vtZcLZC_tR3YTCsstaJlaI2pcZv5NuAGwIeSbCon4e_GFaNwtPVuoSGcqUVzE6VYsxd7Di0s3Nw4cY7B99gvd_5_v7eydcOc1UGmA59OWHKk9bGkfGiOLM6BQiiZSx5xv22NgYQO_wVGt-kcdo2Eaa_iXicaRBdbcG-Cg793iJrgosYnL-1L3u9H8fNOQZmo3MJhdoy3G6LyGeh9DlrC4bXtxds4WWLsGASL4drNme2d8n6tBiq2bnK8wWzuH-f3HN4lu7OBfABWbHFQ3K7607sH5G_TZAfBahJh-UEw5OghbqQC-qCxWg6KjEyB0AwNQMMPpvltLqQPN6Cljmo6qqriiF1DECqKlOVjgjPwMQhemAstrKjLJ82jTCAHutIIaU_6asckfYWVQX2N8YOSxgZHRTzx82wI1r-VqMZrVM7fAK6BtPPXJA_rRL0PianN7LqT8hqURb2GaFeW4nQFzbUnhYq9eMsVVZ6XIeekZKbFvlYr3KiXeJ1rP-RJ5UDJsMExSJBsYBfiQxb5EPTYDjPOXI163sUmwS1EfSplbtUASPDvF7JbsDjAN5LAOfGEidoEb1MrgUvcVpsnFzsuRZ505CxJUbmFbacznkQZ4bxdTyBADcZPOMWeTqX5ebF_IALsCowgGhJyhsGzH--TCkG_SoPOnr7nMNzN-v9sDD0q-Zrs9kw_5vb59dPyWuy3jnpHiVHB73DF-QOAGmBmMaXG2R1MpralwBWJ-krpxEo-XnTSugf9Wasnw |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSIUeEO8uFDASElRqaBI7jsOtWliVRysOVOot8ivalaJktQ_Q3vgP_ENO_AxmEifsVhTEbbUzntjxePw5Hn8m5HlmhUuUdYEuHAu4UTaQiWZBGuoUwBxgYoXfIU9OxfEZf3-enPvcnHmX7d5tSbZnGpClqVocTm3RDnEpDiOexoGQMQsiHkhxlVzjMLXhBQZDMew3EZAKzrP5_KHQxkR0MRyvzUcXcyX7DdMdcn1ZTdXqqyrLtTlpdIvc9GCSHrW9f5tccdUdsn3it8vvkp99hh0FnEenNTYRHI6q351CfaYW1bMa02IAgVI7wcyvVUmb08DzAyhZQpxsTDUK2iuAqLkWqvZCeAaydpiJdVjKzYpy2RfC7HW8xAkl48VYlQhzD6iq0N4cDdZQMzqp2set0BCtv6jZina8Cq9BbmDe_fHtu8-xpw0_7j1yNnr7eXgc-KsdAiNiuQhUKJ3LUhumWeGMBtxnZCZZweLIWAvLJPhL2NjqTEc2Rc6hlGWFgXhhHIAazu6Traqu3C6hYaS4iLkTJjRc6TgrtHIyZEaEVkpmB-RV18-58bzneP1GmTfrHylydIwcHQN-5VIMyMu-wLSl_Lhc9QU6To7BAGwa5c80QM2QVis_SliWQLs4aO5taMIgNpvizvVyH0TmOUDlhKUSQOSAPOvFWBIT4ypXL1sdhHki-5tOwmGVCgvTAXnQenPfsDhhHII6VCDd8PNeAenHNyXVZNzQkONimzF47n43Itaqftn72u-HzL_e7cP_sPuUbH96M8o_vjv98IjcAEzLEV7Eco9sLWZL9xhw40I_aaLDL51lbcM |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bi9NAFB7WLnh58H6prjKCoAubbppJJhPfirgsQhcfLKxPYW6hxZiUNFXqk__Bf-iTP8Nzkmlsi6sIvoWcc-aSzJz5JjnnG0KeJYbbSBrrqcwyL9TSeCJSzIt9FQOYA0ws8Tvk-IyfTsI359H5Hhmvc2HUR20LU-rKNOSTg80k9LzNccAzFGx1PDdZO-UFPx6GceBxETBvGHqCXyL7PAJo3iP7k7O3o_dNhpHTcPQ-v7HaWpl2_fPGArUbPNn9Qb1GriyLuVx9lnm-sUid3CDFunttbMqHwbJWA_1lh_nxv_X_Jrnu4CwdtePvFtmzxW1yeex-2N8hP7oYPwpIk87LGqOTwEL-GhbUxYpRVZUYmAMYmJoZxp6tctrkIy-OwDIHT90U1SgopwCi5mCq0gmhDuQN0TNj0cpWWb7sjDB-Ho-RQsm0nsocgfYRlQWWt8ACS2gZnRVtdSssiJafZLWia2aHlyDXsPJ___rNRfnThqH3LpmcvH736tRzh0t4mgei9qQvrE1i48dJZrUC5KlFIljGgqE2BjZqcIubwKhEDU2MrEcxSzINHktbgFUhu0d6RVnYB4T6QxnyILRc-zqUKkgyJa3wmea-EYKZPhmsB1aqHfM6HgCSp80OTPAU31-K7w-uUsH75EVnMG9JRy5WfY4jNUV3BGVq6bIqoGVI7JWOIpZE0K8QNA-2NMGN6G3xeqynzo0tUgDrEYsFwNg-edqJ0RJD8wpbLlsdBJo8-ZNOFMI-GbbGfXK_nT5dx4KIhbCsQAPirYnVKSAB-rakmE0bInTc7jMG9R6up-BG0y96XofdHP3bs334D7qPyFWA0iGimkAckF5dLe1jgKu1euKc0E-qGZiT |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exploring+the+potential+association+between+brominated+diphenyl+ethers%2C+polychlorinated+biphenyls%2C+organochlorine+pesticides%2C+perfluorinated+compounds%2C+phthalates%2C+and+bisphenol+a+in+polycystic+ovary+syndrome%3A+a+case%E2%80%93control+study&rft.jtitle=BMC+endocrine+disorders&rft.au=Vagi%2C+Sara+J&rft.au=Azziz-Baumgartner%2C+Eduardo&rft.au=Sj%C3%B6din%2C+Andreas&rft.au=Calafat%2C+Antonia+M&rft.date=2014-10-28&rft.pub=BioMed+Central&rft.eissn=1472-6823&rft.volume=14&rft_id=info:doi/10.1186%2F1472-6823-14-86&rft_id=info%3Apmid%2F25348326&rft.externalDocID=PMC4287339 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1472-6823&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1472-6823&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1472-6823&client=summon |